Stimulant Prescription and Risk of Injury among Children with Attention Deficit Hyperactivity Disorder (ADHD) in the United Kingdom (UK): Preliminary Results

Aug-10

Mental Health Neurology Paediatrics Pharmacoepidemiology

AUTHORS : Dr Sudha R Raman (Details fort study: University of North Carolina at Chapel Hill) now works at: Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC 27701, USA – Email: sudha.raman@duke.edu – Profile: https://populationhealth.duke.edu/people/sudha-raman-phd AND https://scholars.duke.edu/person/sudha.raman

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):226-227

DOI : 10.1002/pds.2019

Stimulant Prescription and Risk of Injury among Children with Attention Deficit Hyperactivity Disorder (ADHD) in the United Kingdom (UK): Preliminary Results

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Maternal perinatal anxiety and infant primary care use in 1998–2016: a UK cohort study

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study